Neurological Institute

New York, New York 10032

0 studies enrolling now · 2 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)

Studies at this site

• A Study for Patients Who Completed VITALITY-ALS (CY 4031) — Completed
• A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis — Completed